TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma

Telomerase reverse transcriptase (TERT) activity is up-regulated in several types of tumors including glioblastoma (GBM). In the present study, 128 primary glioblastoma patients were examined for single nucleotide polymorphisms of TERT in blood and in 92 cases for TERT promoter mutations in tumors....

Full description

Bibliographic Details
Main Authors:	Mosrati, Mohamed Ali, Malmström, Annika, Lysiak, Malgorzata, Krysztofiak, Adam, Hallbeck, Martin, Milos, Peter, Hallbeck, Anna-Lotta, Bratthäll, Charlotte, Strandéus, Michael, Stenmark-Askmalm, Marie, Söderkvist, Peter
Format:	Online
Language:	English
Published:	Impact Journals LLC 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599297/

Similar Items

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis
by: Mosrati, Mohamed Ali, et al.
Published: (2015)

Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes
by: Domert, Jakob, et al.
Published: (2016)

Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death
by: Jangamreddy, Jaganmohan R., et al.
Published: (2015)

p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group.
by: Stenmark-Askmalm, M., et al.
Published: (1995)

Quality and Safety of Minimally Invasive Surgery: Past, Present, and Future
by: McCrory, Bernadette, et al.
Published: (2014)

Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis
by: Karlsson, Elin, et al.
Published: (2015)

Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma
by: Park, Chul-Kee, et al.
Published: (2014)

Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma
by: Ahmad, F, et al.
Published: (2016)

Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system
by: Zheng, Lin, et al.
Published: (2012)

Quantifying Intraoperative Workloads Across the Surgical Team Roles: Room for Better Balance?
by: Yu, Denny, et al.
Published: (2016)

A triclinic polymorph of bis(μ-di-tert-butylphosphanido)bis[(di-tert-butylphosphane)palladium(I)]
by: Breunig, Jens, et al.
Published: (2012)

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
by: Yujin Lee, et al.
Published: (2017-08-01)

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials
by: Karlsson, Elin, et al.
Published: (2013)

TERT promoter mutations and monoallelic activation of TERT in cancer
by: Huang, F W, et al.
Published: (2015)

Survival kinase genes present prognostic significance in glioblastoma
by: Varghese, Robin T., et al.
Published: (2016)

Biomarker-based prognostic stratification of young adult glioblastoma
by: Zhang, Rui-qi, et al.
Published: (2015)

Expression and prognostic significance of TCTN1 in human glioblastoma
by: Meng, Delong, et al.
Published: (2014)

Prognostic value of the preoperative immunological profile in patients with glioblastoma
by: Gousias, Konstantinos, et al.
Published: (2014)

Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer
by: Beesley, Jonathan, et al.
Published: (2012)

hTERT promoter polymorphism, -1327C>T, is associated with the risk of epithelial cancer
by: Iizuka, Toshihiko, et al.
Published: (2013)

TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population
by: Yoo, Seung Soo, et al.
Published: (2015)

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
by: Olsson, Hans, et al.
Published: (2013)

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
by: Arita, Hideyuki, et al.
Published: (2016)

Impact of single-incision laparoscopic cholecystectomy (SILC) versus conventional laparoscopic cholecystectomy (CLC) procedures on surgeon stress and workload: a randomized controlled trial
by: Abdelrahman, Amro M., et al.
Published: (2015)

Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.
by: Borg, A., et al.
Published: (1995)

The chemical behavior of terminally tert-butylated polyolefins
by: Klein, Dagmar, et al.
Published: (2015)

Diacetatodi-tert-butyltin(IV)
by: Reichelt, Martin, et al.
Published: (2013)

Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme
by: Griguer, Corinne E., et al.
Published: (2013)

Circulating Endothelial Cells and Procoagulant Microparticles in Patients with Glioblastoma: Prognostic Value
by: Reynés, Gaspar, et al.
Published: (2013)

AKT Pathway Genes Define 5 Prognostic Subgroups in Glioblastoma
by: Joy, Anna, et al.
Published: (2014)

Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma
by: Li, Rui, et al.
Published: (2014)

The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma
by: Yue, Qi, et al.
Published: (2013)

Identification of prognostic biomarkers for glioblastomas using protein expression profiling
by: JUNG, YONG, et al.
Published: (2011)

Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients
by: Mock, Andreas, et al.
Published: (2015)

Expression and prognostic significance of CCL11/CCR3 in glioblastoma
by: Tian, Min, et al.
Published: (2016)

IGF-IR: a new prognostic biomarker for human glioblastoma
by: Maris, C, et al.
Published: (2015)

Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma
by: Yoon, Seon-Jin, et al.
Published: (2016)

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma
by: Kristensen, Lasse S., et al.
Published: (2016)

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
by: Chen, Jun-Rui, et al.
Published: (2016)

Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
by: Mallick, Supriya, et al.
Published: (2015)